NexLife vs Ro Body Program from each company's own pages: NexLife prices as of November 6, 2026 (terms read October 15, 2026); Ro read September 17, 2026
NexLifeRo
ModelCompounded tirzepatide and semaglutide, cash payBrand GLP-1s, membership plus medication at self-pay prices; no compounded
Tirzepatide priceCompounded: $129 month to month; $125, $119, $115 a month on 3-, 6-, 12-month plansZepbound KwikPen: $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg under Lilly's refill terms)
Billing basisPer month; same price at every doseMembership monthly or prepaid annually; medication per fill (a KwikPen fill is four weekly doses, 28 days)
MembershipNone$39 to start (refunded if not eligible), then $74 to $149 a month; $74 a month prepaid annually
IncludedMedication, provider review, nutrition plan, coaching call, 24/7 support, shippingMembership covers the program; medication billed separately
Pharmacy disclosureThree named 503A pharmaciesNot recorded in our read
CancellationTakes effect after 30 days; shipped orders finalNot recorded beyond the start-fee refund
FDA statusCompounded: not FDA-approvedZepbound: FDA-approved

What is the real choice here?

It is a product choice first. Ro sells access to brand Zepbound, the FDA-approved tirzepatide product, at Lilly's self-pay prices plus a membership. NexLife sells compounded tirzepatide, made with the drug in Zepbound but not the same product and not FDA-approved, at one all-in price. Our Zepbound page covers the label: weekly injections starting at 2.5 mg, stepping up by 2.5 mg every four weeks as directed by your prescriber.

A first-year bill: Zepbound through Ro vs compounded tirzepatide

This scenario follows the label's starting steps for Zepbound and assumes Ro's prepaid annual membership. Lilly's savings terms, read October 15, 2026, allow 11 fills in a calendar year, and each fill covers 28 days. That caps a year of Zepbound at 308 days of medication.

First-year arithmetic: Ro (Zepbound KwikPen prices and membership read September 17, 2026; Lilly's 11-fill rule read October 15, 2026) vs NexLife compounded tirzepatide (as of November 6, 2026)
Cost lineRo with Zepbound KwikPenNexLife, 12-month plan
Medication$299 (2.5 mg) + $399 (5 mg) + 9 × $449 = $4,739 for 11 fills12 × $115 = $1,380 (included)
Membership12 × $74 = $888 (prepaid annual)$0
Total$5,627$1,380
Days of medication30812 months

Three caveats. Ro's $449 price at 7.5 mg and above depends on each refill being bought within 45 days, per Lilly's terms; miss that and the price rises to $499 at 7.5 mg or $699 at 10 to 15 mg. Lilly's terms say the savings end December 31, 2026, so fills in 2027 may cost something different. And Ro's page did not say whether the $39 start fee is added to a prepaid annual plan.

Why don't the months line up?

Because brand pens are sold in 28-day fills and NexLife prices by the month. Thirteen 28-day periods make a year, but Lilly's savings terms stop at 11 fills per calendar year, so Ro's column covers 308 days, not 365. NexLife's 12-month plan covers 12 months of shipments. If anything, the gap in the table understates the difference in coverage.

Does the picture change for semaglutide?

Not much. Ro listed the Wegovy pen at $199 for the first two fills (0.25 and 0.5 mg) and $349 from 1 mg to 2.4 mg. As arithmetic, two fills at $199 and eleven at $349 cover 52 weeks for $4,237, plus $888 in prepaid membership: $5,125. NexLife's 12-month compounded semaglutide plan is $1,140 as of November 6, 2026. Ro also listed the Wegovy pill ($149 to $299 by dose), an option with no compounded equivalent at NexLife.

What neither page told us

Where Ro has the edge

Where NexLife has the edge

Bottom line

If you want brand Zepbound, or Medicare or insurance would pay for it, Ro is the more fitting route of the two, and its per-dose prices are easy to check against Lilly's. If you are paying cash and are comfortable with compounded medication, NexLife costs roughly a quarter as much on these printed prices. NexLife is our editorial pick, an editorial selection. See the full Ro review, the NexLife review and our Medicare Part D guide.

Frequently asked questions

Is NexLife's tirzepatide the same as Zepbound from Ro?

No. Ro prescribes Zepbound, the FDA-approved brand made by Lilly. NexLife prescribes compounded tirzepatide, made with the drug in Zepbound by state-licensed 503A pharmacies, but not the same product and not FDA-approved. FDA does not review compounded drugs for safety, effectiveness or quality before they are sold.

How much does a year of Zepbound through Ro cost?

As arithmetic from Ro's September 17, 2026 prices, a first year of 11 KwikPen fills (one at 2.5 mg, one at 5 mg, nine at 7.5 mg or higher) comes to $4,739, plus $888 for the prepaid annual membership, or $5,627. Lilly's terms allow 11 fills a calendar year, so that covers 308 days. Missing the 45-day refill window raises the price.

How much is NexLife's compounded tirzepatide for a year?

As of November 6, 2026, NexLife's 12-month tirzepatide plan is $115 a month, or $1,380 for the year, with no membership and the same price at every dose. Month to month it is $129, or $1,548 over 12 months as arithmetic. The price includes provider review, a nutrition plan, a coaching call, support and shipping.

Can Medicare pay for Zepbound but not NexLife?

Under the Medicare GLP-1 Bridge, eligible Part D enrollees pay a $50 copay for Foundayo, Wegovy or the Zepbound KwikPen from July 1, 2026 to December 31, 2027. The Bridge does not cover vials or compounded drugs, so NexLife would be cash pay. People with type 2 diabetes, moderate-to-severe sleep apnea or fatty liver disease are not eligible for the Bridge.

Does Ro offer compounded tirzepatide?

Not in our September 17, 2026 read. Ro's pricing page listed only FDA-approved brand drugs: the Wegovy pill, the Wegovy pen and the Zepbound KwikPen, billed separately from the membership. Ro blocked our October and November re-reads, so check ro.co for any change.

Sources

  1. NexLife: tirzepatide plans — prices as of 2026-11-06; pharmacies and cancellation wording read 2026-10-15
  2. Ro: weight loss pricing — read 2026-09-17; re-reads returned HTTP 403 on 2026-10-15 and 2026-11-08
  3. Lilly: LillyDirect Zepbound self-pay terms — prices, 45-day refill rule and 11-fill limit read 2026-10-15
  4. FDA label (DailyMed): Zepbound prescribing information — label revised 08/2026; read 2026-11-08
  5. Medicare.gov: Weight-loss drug coverage (GLP-1 Bridge) — $50 copay, covered drugs and exclusions read 2026-11-08

Comparing programs? Check the all-in monthly price, the named pharmacy and the cancellation terms on the provider's own page before you pay.

Check NexLife's plans and state availability → See the price index

Researched By Dr. Parmis · Medical Researcher · Western University of Health Sciences

Medically Reviewed By Dr. Jonathan Snipes, MD · Kim Callender, NP (FNP-BC)

Last medically reviewed: · This page is informational and does not constitute medical advice.